NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,891,998 | +53.1% | 178,350 | +68.3% | 0.00% | +100.0% |
| Q2 2023 | $5,155,539 | -6.5% | 105,950 | +6.7% | 0.00% | -33.3% |
| Q1 2023 | $5,514,788 | +33.5% | 99,330 | -3.4% | 0.00% | +50.0% |
| Q4 2022 | $4,129,386 | +14.3% | 102,798 | +24.6% | 0.00% | 0.0% |
| Q3 2022 | $3,614,000 | +64.3% | 82,471 | +32.9% | 0.00% | +100.0% |
| Q2 2022 | $2,199,000 | -19.4% | 62,038 | -7.5% | 0.00% | 0.0% |
| Q1 2022 | $2,727,000 | -78.4% | 67,044 | -50.5% | 0.00% | -83.3% |
| Q4 2021 | $12,651,000 | -9.7% | 135,462 | +7.8% | 0.01% | -25.0% |
| Q3 2021 | $14,009,000 | +14.4% | 125,712 | +16.6% | 0.01% | +14.3% |
| Q2 2021 | $12,241,000 | +14.6% | 107,821 | +2.5% | 0.01% | 0.0% |
| Q1 2021 | $10,682,000 | +167.4% | 105,196 | +162.0% | 0.01% | +133.3% |
| Q4 2020 | $3,995,000 | +43.9% | 40,146 | +4.5% | 0.00% | +50.0% |
| Q3 2020 | $2,776,000 | +97.2% | 38,423 | +36.1% | 0.00% | +100.0% |
| Q2 2020 | $1,408,000 | +82.4% | 28,233 | +9.2% | 0.00% | 0.0% |
| Q1 2020 | $772,000 | -12.1% | 25,860 | -0.7% | 0.00% | 0.0% |
| Q4 2019 | $878,000 | +10.0% | 26,055 | +7.1% | 0.00% | 0.0% |
| Q3 2019 | $798,000 | +111.7% | 24,326 | +78.1% | 0.00% | – |
| Q2 2019 | $377,000 | – | 13,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |